References
- Woods AK, Hoffmann DS, Weydert CJ et al. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension57(1), 94–102 (2011).
- Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension46(5), 1077–1085 (2005).
- Li Z, Zhang Y, Ying Ma J et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension50(4), 686–692 (2007).
- Bergmann A, Ahmad S, Cudmore M et al. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J. Cell Mol. Med.14(6B), 1857–1867 (2010).
- Suzuki H, Ohkuchi A, Matsubara S et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension54(5), 1129–1135 (2009).
- LaMarca B, Parrish M, Ray LF et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension54(4), 905–909 (2009).
- Siddiqui AH, Irani RA, Zhang Y et al. Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice. Am. J. Hypertens.24(5), 606–612 (2011).
- Sunderland N, Hennessy A, Makris A. Animal models of pre-eclampsia. Am. J. Reprod. Immunol. DOI: 10.1111/j.1600-0897.2010.00929.x. (2010) (Epub ahead of print).
- LaMarca B, Wallukat G, Llinas M et al. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor α in pregnant rats. Hypertension52(6), 1168–1172 (2008).
- Gilbert JS, Verzwyvelt J, Colson D et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension55(2), 380–385 (2010).